ConductScience.org, home

Paper2473465

Synthesis of gelatin microspheres containing interferon.

Tabata Y and 1 other. Pharm Res, 1989. Cited by 100 papers, by iCite.

Cite this record

ConductScience Library. Synthesis of gelatin microspheres containing interferon. Papers, record 2473465. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2473465

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Synthesis of gelatin microspheres containing interferon.
PubMed
Journal
Pharm Res
PubMed
Year
1989
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
100
iCite
Relative citation ratio, by iCite
4.26
iCite
Revised in PubMed
2026-10-16
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Tabata YY
2Ikada YY

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
InterferonsMajor topic
Chemistry, Pharmaceutical
Gelatin
Glutaral
Indicators and Reagents
Iodine Radioisotopes
Microscopy, Electron, Scanning
Microspheres
Phagocytosis
Time Factors

Source PubMed

Download CSV of topics

References16

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
12410097Treatment regimen and host T-cell-dependent therapeutic effect of interferon in mouse solid tumors.Cancer Res1985https://conductscience.org/library/papers/2410097PubMed
24813256Microencapsulation of a waxy solid: wall thickness and surface appearance studies.J Pharm Sci1974https://conductscience.org/library/papers/4813256PubMed
33871818Direct evidence for the role of LGL in the inhibition of experimental tumor metastases.J Immunol1985https://conductscience.org/library/papers/3871818PubMed
43136117Potentiation of antitumor activity of macrophages by recombinant interferon alpha A/D contained in gelatin microspheres.Jpn J Cancer Res1988https://conductscience.org/library/papers/3136117PubMed
52578878Direct and indirect effects of interferon on in vivo murine tumor cell growth.Cancer Res1985https://conductscience.org/library/papers/2578878PubMed
64673189Protein measurement by ninhydrin determination of amino acids released by alkaline hydrolysis.Anal Biochem1972https://conductscience.org/library/papers/4673189PubMed
713984810A new oral gelatinized sustained-release dosage form.J Pharm Sci1963https://conductscience.org/library/papers/13984810PubMed
82890735Macrophage activation through phagocytosis of muramyl dipeptide encapsulated in gelatin microspheres.J Pharm Pharmacol1987https://conductscience.org/library/papers/2890735PubMed
96158375Augmentation of human monocyte-mediated cytolysis by interferon.Cell Immunol1980https://conductscience.org/library/papers/6158375PubMed
106987401Methods to quantify endocytosis: a review.J Reticuloendothel Soc1980https://conductscience.org/library/papers/6987401PubMed
11881643Role of intramuscular administration of water-in-oil emulsions as a method for increasing the delivery of anticancer agents to regional lymphatics.J Pharmacokinet Biopharm1977https://conductscience.org/library/papers/881643PubMed
124164561Uptake by mononuclear phagocytes of protein-coated bentonite particles stabilized with a carbodiimide.J Immunol1967https://conductscience.org/library/papers/4164561PubMed
13881644An application of water-in-oil and gelatin-microsphere-in-oil emulsions to specific delivery of anticancer agent into stomach lymphatics.J Pharmacokinet Biopharm1977https://conductscience.org/library/papers/881644PubMed
144386610Gelatin coacervate microcapsules containing sulphamerazine: their preparation and the in vitro release of the drug.J Pharm Pharmacol1968https://conductscience.org/library/papers/4386610PubMed
154960890The dissociation of the attachment and ingestion phases of phagocytosis by macrophages.Exp Cell Res1967https://conductscience.org/library/papers/4960890PubMed
1614097352THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY.Biochem J1963https://conductscience.org/library/papers/14097352PubMed

Download CSV of references

Cited by14

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 100 citations.

PMIDTitleJournalYearIn PapersSource
34012664131Iodine-DEM TACE vs. conventional TACE in cirrhotic patients with hepatocellular carcinoma: a single center experiment.J Gastrointest Oncol2021https://conductscience.org/library/papers/34012664PubMed
33086577Gelatin Microsphere for Cartilage Tissue Engineering: Current and Future Strategies.Polymers (Basel)2020https://conductscience.org/library/papers/33086577PubMed
32154334A cancer invasion model of cancer-associated fibroblasts aggregates combined with TGF-β1 release system.Regen Ther2020https://conductscience.org/library/papers/32154334PubMed
25085588Pharmacokinetics of gelatin sponge microparticles in a rabbit VX2 liver tumor model of hepatic arterial chemoembolization.Tumour Biol2014https://conductscience.org/library/papers/25085588PubMed
23354736In vivo investigation of ceftiofur-loaded gelatin and PLGA microspheres in beagle dogs.J Mater Sci Mater Med2013https://conductscience.org/library/papers/23354736PubMed
23139710Vascular regeneration by pinpoint delivery of growth factors using a microcatheter reservoir system in a rabbit hind-limb ischemia model.Exp Ther Med2012https://conductscience.org/library/papers/23139710PubMed
22973103Preparation of bioactive interferon alpha-loaded polysaccharide nanoparticles using a new approach of temperature-induced water phase/water-phase emulsion.Int J Nanomedicine2012https://conductscience.org/library/papers/22973103PubMed
22342597An in situ cross-linking hybrid hydrogel for controlled release of proteins.Acta Biomater2012https://conductscience.org/library/papers/22342597PubMed
20959369Anti-tumour effects of transcatheter arterial embolisation administered in combination with thalidomide in a rabbit VX2 liver tumour model.Br J Radiol2011https://conductscience.org/library/papers/20959369PubMed
20440852Direct in vivo injection of 131I-GMS and its distribution and excretion in rabbit.World J Gastroenterol2010https://conductscience.org/library/papers/20440852PubMed
20019172A combination of cisplatin-eluting gelatin microspheres and flavopiridol enhances anti-tumour effects in a rabbit VX2 liver tumour model.Br J Radiol2010https://conductscience.org/library/papers/20019172PubMed
19774478Preparation and evaluation of danofloxacin mesylate microspheres and its pharmacokinetics in pigs.Vet Res Commun2009https://conductscience.org/library/papers/19774478PubMed
17923785Degradable gelatin microspheres as an embolic agent: an experimental study in a rabbit renal model.Korean J Radiol2007https://conductscience.org/library/papers/17923785PubMed
1614973Optimized formulation of magnetic chitosan microspheres containing the anticancer agent, oxantrazole.Pharm Res1992https://conductscience.org/library/papers/1614973PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2473465

GET https://conductscience.org/api/papers/v1/2473465/authors